Joseph James Reilly, senior vice president and chief accounting officer of Ardelyx Inc., sold 3,982 shares of the company’s common stock on August 21, 2026, for a total value of $15,358.
The transactions were executed automatically under an existing sell-to-cover arrangement to cover applicable withholding taxes on the vesting of restricted stock units. The weighted average sale price was $3.8569 per share, with individual trades ranging between $3.648 and $3.984 per share.
Following the sale, Reilly directly holds 145,854 shares of Ardelyx common stock. Ardelyx’s shares have declined 55% from their 52-week high of $8.40 to trade near the recent low of $3.73.
Ardelyx reported a 31% year-over-year increase in second-quarter revenue, reaching a record $118 million. However, the company lowered its full-year guidance for its product IBSRELA and withdrew its revenue target for XPHOZAH. Option trading activity for Ardelyx surged to 11,147 contracts, the highest since April 2025, with 471 call contracts and 10,676 put contracts traded.
